全身超音波設備市場（按設備類型、技術、應用和最終用戶分類）—2026-2032年全球預測

預計到 2025 年，全身超音波設備市場規模將達到 72.7 億美元，到 2026 年將成長至 76 億美元，到 2032 年將達到 103.4 億美元，複合年成長率為 5.16%。

關鍵市場統計數據
基準年 2025	72.7億美元
預計年份：2026年	76億美元
預測年份 2032	103.4億美元
複合年成長率 (%)	5.16%

全面介紹全身超音波，闡述技術進步、臨床應用促進因素以及策略決策者在採購方面需要考慮的因素。

全身超音波已從一種小眾的輔助診斷手段迅速發展成為核心影像方式，貫穿臨床工作流程、照護現場診斷和門診醫療服務。探頭小型化、影像處理技術和電池性能的進步拓展了超音波的應用範圍，使臨床醫生能夠將影像檢查從放射科轉移到床邊、診室和遠端地點。因此，採購團隊、臨床負責人和醫療設備開發人員在選擇系統時，面臨著影像品質、工作流程整合和整體擁有成本之間相互關聯的挑戰。

硬體、人工智慧和醫療服務模式的進步如何融合，正在重塑醫療機構中全身超音波的部署、採購和供應商策略？

全身超音波領域正經歷變革性的轉變，這主要由技術融合、臨床需求和組織變革共同驅動。在技​​術方面，先進的波束形成技術、人工智慧驅動的圖像最佳化以及可攜式硬體的整合，改變了人們對診斷級系統的預期。這些技術進步輔以更聰明的使用者介面和自動化測量功能，降低了對操作者的依賴性，並將潛在使用者群體擴展到傳統超音波之外。

分析近期美國關稅如何影響超音波設備買家的籌資策略、供應商選擇決策和生命週期成本管理。

到2025年，美國關稅和貿易政策調整的累積影響將對全身超音波設備的採購週期、供應商籌資策略和產品定價結構產生新的影響。供應鏈經理和採購主管必須應對進口商品到岸成本增加、前置作業時間延長以及需要靈活的採購方式來降低風險等挑戰。因此，許多企業正在轉向供應商網路多元化、加強供應商關係以及強調區域夥伴關係，以提高韌性並縮短補貨時間。

詳細的細分分析將設備類型、臨床應用、最終用戶優先事項和核心成像技術與實際的採購和實施選擇聯繫起來。

主要なセグメメテーション分析により、臨床二ズと產品設計,導入経路,商業性的プチーチ接點が器物特性が重要な事件では、カートベーsushisutemuは復雑な影像診斷niーズに適しは復雑ャチネズに適したチャチネチーションreベルの機能を提供し、ハンドヘルドデバイスは分散型環境での迅速な就地檢驗と攜帯性を実現します。また可攜式シテムは、混合使用の臨床環境において影像性能と機動性のバランをみ臨床応用分野において、心臓學構造,機能評估価のための心エコー技術の進歩を用し、筋骨格系イー技術の進歩を用し、筋骨格系イー技術ヂ解像度riniaトランデューサーと動的評価機能の恩恵を受け、產婦人科は信頼性の高いを,骨盤イヂークfuroに依存し、放射線科は全身超音波を多重模式診斷経路に統合し、泌尿系統科は手技後續觀察のための標的イメージングを利用し、血管応用分野ではドップラー感度と再現性のある血流測定値が優先されます。エンドユーザーは購入基準とサービス期待に影響を與えます。門診護理環境優先考慮成本、易用性和吞吐量；診斷中心優先考慮吞吐量和計費最佳化；醫院需要廣泛的影像模式支援、與企業級影像系統的整合以及完善的服務協議。此外，技術細分也是一項競爭優勢：多普勒成像對於血流評估至關重要，2D成像仍然是結構可視化的基礎，而3D/四維成像功能則拓展了其在產科、手術規劃和容積分析等領域的應用。透過將這些細分維度與臨床工作流程和採購因素結合，相關人員可以確定產品特性和商業模式最符合實際需求的領域。

深入分析美洲、歐洲、中東和非洲以及亞太地區在採用路徑、報銷機制和服務需求方面的差異，提供關鍵的區域性洞察。

區域趨勢是技術商業化、規模化和整合到醫療服務路徑中的核心所在。在美洲，醫療系統日益重視拓展門診服務能力，因此便攜性、快速部署和隨時隨地培訓成為採購者的首要考量。私人和公共支付方的結構影響採購週期和報銷獎勵，進而影響臨床醫生偏好的設備和支援模式。在歐洲、中東和非洲，法規環境的差異和醫療基礎設施的不均衡，使得適應性和模組化成為競爭優勢。能夠提供可擴展平台、多語言培訓和靈活資金籌措方案的供應商，更有能力滿足不同醫療機構的需求。在亞太地區，數位科技的快速普及、對照護現場能力的大力投資以及不斷壯大的供應商生態系統，正在推動價格/性能比和社區服務網路領域的激烈競爭。每個地區的技術吸收率、勞動力發展模式和資本配置重點各不相同。因此，成功的商業策略需要根據當地的臨床工作流程、報銷實際情況和服務預期，量身訂做市場推廣方案。了解這些區域差異，可以更有效地使您的產品藍圖與您的市場推廣計劃保持一致。

供應商行為的策略競爭概覽，其中平台整合、利基創新和服務模式將決定差異化和長期商業性成功。

公司發展趨勢反映了平台投資、細分市場專業化和策略聯盟的綜合影響，這些因素正在影響企業的競爭地位。主要企業正致力於建立硬體、軟體分析和服務一體化的生態系統，以創造差異化的臨床工作流程和持續的商機。同時，規模較小的創新者則專注於攜帶式設備、專用應用或獨特的成像方式，透過在特定臨床路徑中提供針對性價值來挑戰現有企業。設備製造商和軟體開發商之間的合作正在加速人工智慧驅動的測量工具、工作流程自動化和雲端影像管理的部署，而與經銷商和臨床培訓機構的合作則正在將業務拓展到新的臨床領域。

為製造商、醫療系統和經銷商提供切實可行的、優先排序的建議，以將技術優勢轉化為持續的臨床應用和商業性優勢。

針對行業領導者的具體建議著重於協調產品開發、商業策略和臨床合作，以加速產品普及並最大化價值。首先，優先考慮模組化設計和軟體可升級性，以延長設備生命週期並快速回應不斷變化的臨床需求。其次，投資以臨床醫生為中心的培訓和資質認證流程，以減少影像擷取和解讀的差異，進而提高非傳統使用者的可靠性。第三，制定清晰的服務和支援提案，結合預防性保養、快速的零件供應和以結果為導向的培訓，以最大限度地減少營運中斷。

本分析所依據的穩健調查方法，結合了初步質性訪談、二次文獻檢驗和資料三角驗證，從而得出可操作和檢驗的研究結果。

本分析的調查方法結合了與主題專家、臨床醫生、採購負責人和行業高管進行的定性研究，以及對同行評審文獻、監管文件和行業技術規範等資訊的嚴謹的二次綜合分析。主要訪談旨在探討臨床工作流程、決策標準和服務期望，確保所獲得的見解反映的是實際操作情境而非理論能力。二次研究則檢驗了技術趨勢、監管動態以及支持臨床效用的已發表證據。

總之，我們綜合分析了技術進步、臨床應用模式和策略採購考量如何共同決定全身超音波的未來發展軌跡。

總之，全身超音波正處於技術成熟與不斷變化的臨床和操作需求交匯的轉折點。便攜性提升、先進的影像處理技術和智慧型使用者介面的協同作用，正在拓展該技術在從門診到重症監護病房等各種環境中的應用。同時，採購和商業策略必須適應區域趨勢、關稅主導的供應鏈變化，以及軟體和服務在定義長期價值方面日益成長的重要性。相關人員，將更有利於把創新轉化為常規臨床應用。

目錄

第1章：序言

第2章調查方法

• 研究設計
• 研究框架
• 市場規模預測
• 數據三角測量
• 調查結果
• 調查前提
• 調查限制

第3章執行摘要

• 首席主管觀點
• 市場規模和成長趨勢
• 2025年市佔率分析
• FPNV定位矩陣，2025
• 新的商機
• 下一代經營模式
• 產業藍圖

第4章 市場概覽

• 產業生態系與價值鏈分析
• 波特五力分析
• PESTEL 分析
• 市場展望
• 上市策略

第5章 市場洞察

• 消費者洞察與終端用戶觀點
• 消費者體驗基準
• 機會地圖
• 分銷通路分析
• 價格趨勢分析
• 監理合規和標準框架
• ESG與永續性分析
• 中斷和風險情景
• 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 全身超音波設備市場：依設備分類

• 推車底座
• 手持式
• 可攜式的

第9章 全身超音波設備市場：依技術分類

• 多普勒
• 3D/4D
• 2D

第10章 全身超音波設備市場：依應用領域分類

• 心臟病學
• 肌肉骨骼系統
• 婦產科
• 放射科
• 泌尿系統
• 血管

第11章 全身超音波設備市場（依最終用戶分類）

• 門診護理設施
• 診斷中心
• 醫院

第12章 全身超音波設備市場：依地區分類

• 美洲
  • 北美洲
  • 拉丁美洲
• 歐洲、中東和非洲
  • 歐洲
  • 中東
  • 非洲
• 亞太地區

第13章 全身超音波設備市場（依類別分類）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第14章 各國全身超音波設備市場

• 美國
• 加拿大
• 墨西哥
• 巴西
• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 中國
• 印度
• 日本
• 澳洲
• 韓國

第15章美國全身超音波設備市場

第16章 中國全身超音波設備市場

第17章 競爭格局

• 市場集中度分析，2025年
  • 濃度比（CR）
  • 赫芬達爾-赫希曼指數 (HHI)
• 近期趨勢及影響分析，2025 年
• 2025年產品系列分析
• 基準分析，2025 年
• Canon Medical Systems Corporation
• Clarius Mobile Health Corp.
• Esaote SpA
• Fujifilm Holdings Corporation
• GE HealthCare Technologies, Inc.
• Hitachi, Ltd.
• Konica Minolta, Inc.
• Koninklijke Philips NV
• Mindray Medical International Limited
• Samsung Medison Co., Ltd.
• Siemens Healthineers AG

The Whole Body Ultrasound Equipment Market was valued at USD 7.27 billion in 2025 and is projected to grow to USD 7.60 billion in 2026, with a CAGR of 5.16%, reaching USD 10.34 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 7.27 billion
Estimated Year [2026]	USD 7.60 billion
Forecast Year [2032]	USD 10.34 billion
CAGR (%)	5.16%

Comprehensive introduction to whole body ultrasound that frames technological evolution, clinical adoption drivers, and procurement considerations for strategic decision-makers

Whole body ultrasound has rapidly evolved from a niche diagnostic adjunct to a core imaging modality that intersects clinical workflows, point-of-care diagnostics, and ambulatory care delivery. Advances in probe miniaturization, image processing, and battery performance have broadened the contexts in which ultrasound can be used, enabling clinicians to move imaging from the radiology suite to bedside, clinic rooms, and remote settings. As a result, procurement teams, clinical leaders, and device innovators face interconnected pressures to balance image quality, workflow integration, and total cost of ownership when selecting systems.

Moreover, parallel developments in software-driven image enhancement, cloud-native data management, and regulatory harmonization have changed how institutions evaluate vendor roadmaps and lifecycle support. Clinical adoption patterns now prioritize modalities that reduce time-to-diagnosis and improve throughput without compromising diagnostic confidence. Consequently, stakeholders must consider not only device specifications but also interoperability, training pathways, and support models that drive sustained clinical use. In this landscape, an informed introduction synthesizes technological evolution with operational realities to frame strategic decisions about equipment acquisition, staff training, and partnership opportunities.

How converging advancements in hardware, AI, and care delivery models are reshaping whole body ultrasound adoption, procurement, and vendor strategies across care settings

The landscape for whole body ultrasound is undergoing transformative shifts driven by convergent technology, clinical need, and organizational change. On the technology axis, the integration of advanced beamforming, AI-enabled image optimization, and portable hardware has shifted expectations for what constitutes a diagnostic-grade system. These technical advances are complemented by smarter user interfaces and automated measurements that reduce operator dependency, thereby expanding the pool of potential examiners beyond traditional sonographers.

Clinically, rising demand for point-of-care diagnostics and value-based care models is prompting clinicians to prioritize modalities that accelerate diagnosis, reduce downstream testing, and enable longitudinal monitoring. Operationally, health systems are reallocating imaging capacity to meet outpatient demand while balancing staffing constraints and budgetary pressures. Concurrently, vendor strategies are evolving toward platform-based offerings that bundle devices, software subscriptions, and services to create sticky commercial relationships. Taken together, these transformative shifts create a market where agility, interoperability, and evidence of clinical effectiveness determine which technologies scale across diverse care pathways.

Analyzing how recent United States tariff measures have reshaped procurement strategies, supplier sourcing decisions, and lifecycle cost management for ultrasound buyers

In 2025 the cumulative impact of tariffs and trade policy adjustments in the United States has introduced new considerations for procurement cycles, vendor sourcing strategies, and product pricing structures for whole body ultrasound equipment. Supply chain managers and purchasing directors must navigate increased landed costs for imports, extended lead times, and the need for more flexible sourcing to mitigate exposure. As a result, many organizations are shifting toward diversified supplier networks, closer supplier relationships, and increased emphasis on regional partnerships that can improve resilience and shorten replenishment horizons.

At the same time, vendors face choices about where to allocate manufacturing capacity and which product lines to prioritize for domestic assembly versus offshore production. These decisions have downstream consequences for warranties, spare parts availability, and service networks. Healthcare providers respond by negotiating total cost agreements that cover lifecycle services and by demanding clearer transparency around component sourcing. Consequently, tariffs have become a persistent part of procurement risk assessments, influencing contract terms, inventory policies, and strategic vendor selection without altering the fundamental clinical value proposition of ultrasound as a versatile diagnostic tool.

In-depth segmentation insights connecting equipment typologies, clinical applications, end-user priorities, and core imaging technologies to practical purchasing and deployment choices

Key segmentation insights reveal where clinical needs intersect with product design, adoption pathways, and commercial approaches. When equipment distinctions matter, cart based systems deliver high-channel counts and workstation-level capabilities suitable for complex imaging needs, handheld devices enable rapid point-of-care screening and portability for decentralized settings, and portable systems strike a balance between image performance and mobility for mixed-use clinical environments. Across clinical applications, cardiology leverages echocardiographic advancements for structural and functional assessment, musculoskeletal imaging benefits from high-resolution linear transducers and dynamic assessment capabilities, obstetrics and gynecology depend on reliable fetal and pelvic imaging workflows, radiology integrates whole body ultrasound into multimodality diagnostic pathways, urology uses targeted imaging for procedural guidance and surveillance, and vascular applications prioritize Doppler sensitivity and reproducible flow metrics. End users influence purchase criteria and service expectations; ambulatory care settings emphasize cost, ease-of-use, and throughput, diagnostic centers prioritize throughput and billing optimization, and hospitals require broad modality support, integration with enterprise imaging systems, and robust service agreements. Finally, technology segmentation informs competitive differentiation: Doppler remains essential for flow assessment, Two D imaging continues to be the foundation for structural visualization, and Three D/Four D capabilities expand obstetric, surgical planning, and volumetric analysis use cases. By mapping these segmentation axes to clinical workflows and procurement drivers, stakeholders can identify where product features and commercial models align most closely with real-world needs.

Critical regional insights detailing how the Americas, Europe Middle East and Africa, and Asia-Pacific evolve differently in adoption pathways, reimbursement, and service requirements

Regional dynamics are central to how technologies commercialize, scale, and integrate into care pathways. In the Americas, healthcare systems are increasingly focused on outpatient capacity expansion, making portability, rapid deployment, and site-agnostic training high-priority considerations for buyers. Private and public payer structures shape procurement cycles and reimbursement incentives, which in turn influence the devices and support models preferred by clinicians. Across Europe, Middle East & Africa, varied regulatory environments and heterogeneous healthcare infrastructure create a market where adaptability and modularity are competitive advantages; vendors that provide scalable platforms, multi-language training, and flexible financing options are better positioned to serve diverse institutional profiles. In the Asia-Pacific region, rapid digital adoption, strong investment in point-of-care capabilities, and a growing supplier ecosystem drive intense competition on price-performance and localized service networks. Each region exhibits different rates of technology absorption, workforce training models, and capital allocation priorities, so successful commercial strategies tailor go-to-market approaches to local clinical workflows, reimbursement realities, and service expectations. Understanding these regional contours enables more effective alignment between product roadmaps and market entry plans.

Strategic competitive overview of supplier behaviors showing how platform integration, niche innovation, and service models determine differentiation and long-term commercial success

Company dynamics reflect a mix of platform investment, niche specialization, and strategic partnerships that influence competitive positioning. Leading manufacturers focus on integrated ecosystems that combine hardware, software analytics, and services to create differentiated clinical workflows and recurring revenue opportunities. At the same time, smaller innovators concentrate on handheld devices, focused applications, or unique imaging modalities that challenge incumbents by offering targeted value in specific clinical pathways. Partnerships between device makers and software developers accelerate the delivery of AI-driven measurement tools, workflow automation, and cloud-enabled image management, while alliances with distributors and clinical training providers extend reach into new care settings.

Service models and aftermarket support are increasingly decisive in procurement decisions, as customers evaluate not only initial acquisition cost but also uptime guarantees, spare part logistics, and training programs that ensure sustained clinical utility. Competitive strategies also vary by region, with some companies prioritizing direct sales and service in mature markets and indirect distribution through local partners in emerging regions. Overall, the competitive landscape rewards firms that demonstrate clinical evidence, offer seamless interoperability, and provide credible long-term support commitments.

Practical and prioritized recommendations for manufacturers, health systems, and distributors to convert technological strengths into sustained clinical adoption and commercial advantage

Actionable recommendations for industry leaders focus on aligning product development, commercial strategy, and clinical engagement to accelerate adoption and maximize value. First, prioritize modular design and software upgradability to extend device lifecycles and respond rapidly to evolving clinical requirements. Second, invest in clinician-centered training and credentialing pathways that reduce variability in image acquisition and interpretation, thereby increasing confidence among non-traditional users. Third, develop clear service and support propositions that bundle preventative maintenance, rapid parts logistics, and outcome-oriented training to reduce total operational disruption.

Moreover, pursue strategic partnerships that combine hardware strengths with analytics and informatics capabilities to deliver measurable workflow improvements. From a commercial perspective, tailor go-to-market models to regional reimbursement practices and procurement cycles, offering flexible financing and subscription options where capital constraints exist. Finally, incorporate supply chain resilience into product planning by diversifying component sources and strengthening regional service hubs to minimize lead-time exposure. Together, these recommendations create a pragmatic roadmap for leaders to convert technological capability into sustained clinical and commercial impact.

Robust research methodology integrating primary qualitative interviews, secondary literature validation, and data triangulation to produce actionable and verifiable insights

The research methodology underpinning this analysis combines primary qualitative engagement with domain experts, clinicians, procurement officers, and industry executives alongside rigorous secondary-source synthesis from peer-reviewed literature, regulatory documents, and industry technical specifications. Primary interviews were structured to explore clinical workflows, decision criteria, and service expectations, ensuring insights reflect operational realities rather than theoretical capability. Secondary research validated technological trends, regulatory developments, and published evidence supporting clinical utility.

Data triangulation was applied to reconcile differing perspectives and to surface consensus where it exists, with special attention to device performance attributes, training requirements, and service model impacts. Throughout the process, care was taken to avoid reliance on single-source estimates or proprietary databases alone; instead, findings emphasize reproducible observations and documented industry practice. This methodology supports actionable conclusions by grounding strategic implications in a blend of practitioner experience and verifiable technical documentation.

Conclusion synthesizing how technological progress, clinical adoption patterns, and strategic procurement considerations collectively define the future trajectory of whole body ultrasound

In conclusion, whole body ultrasound stands at an inflection point where technological readiness meets evolving clinical and operational demands. The combined effects of improved portability, enhanced image processing, and smarter user interfaces are expanding the modality's role across settings that range from ambulatory clinics to high-acuity hospital departments. At the same time, procurement and commercial strategies must adapt to regional dynamics, tariff-driven supply chain shifts, and the growing importance of software and services in defining long-term value. Stakeholders who align product design with clinician needs, invest in training and support, and build resilient supply and service networks will be best positioned to translate innovation into routine clinical use.

Sustained success requires an integrated approach that balances hardware performance, software capability, and credible service promises. For industry participants, the path forward lies in demonstrating clinical impact, ensuring regulatory preparedness, and partnering effectively with care providers to embed ultrasound into standard diagnostic pathways. By focusing on these areas, organizations can help realize the full clinical and economic potential of whole body ultrasound across diverse healthcare environments.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Whole Body Ultrasound Equipment Market, by Equipment Type

• 8.1. Cart Based
• 8.2. Handheld
• 8.3. Portable

9. Whole Body Ultrasound Equipment Market, by Technology

• 9.1. Doppler
• 9.2. Three D/Four D
• 9.3. Two D

10. Whole Body Ultrasound Equipment Market, by Application

• 10.1. Cardiology
• 10.2. Musculoskeletal
• 10.3. Obstetrics & Gynecology
• 10.4. Radiology
• 10.5. Urology
• 10.6. Vascular

11. Whole Body Ultrasound Equipment Market, by End User

• 11.1. Ambulatory Care Settings
• 11.2. Diagnostic Centers
• 11.3. Hospitals

12. Whole Body Ultrasound Equipment Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Whole Body Ultrasound Equipment Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Whole Body Ultrasound Equipment Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Whole Body Ultrasound Equipment Market

16. China Whole Body Ultrasound Equipment Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Canon Medical Systems Corporation
• 17.6. Clarius Mobile Health Corp.
• 17.7. Esaote S.p.A.
• 17.8. Fujifilm Holdings Corporation
• 17.9. GE HealthCare Technologies, Inc.
• 17.10. Hitachi, Ltd.
• 17.11. Konica Minolta, Inc.
• 17.12. Koninklijke Philips N.V.
• 17.13. Mindray Medical International Limited
• 17.14. Samsung Medison Co., Ltd.
• 17.15. Siemens Healthineers AG

LIST OF FIGURES

• FIGURE 1. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CART BASED, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CART BASED, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CART BASED, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HANDHELD, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY THREE D/FOUR D, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY THREE D/FOUR D, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY THREE D/FOUR D, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TWO D, BY REGION, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TWO D, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TWO D, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY VASCULAR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 52. AMERICAS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 53. AMERICAS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 54. AMERICAS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 55. AMERICAS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 56. AMERICAS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 57. NORTH AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 58. NORTH AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 59. NORTH AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 60. NORTH AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 61. NORTH AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 62. LATIN AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. LATIN AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 64. LATIN AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 65. LATIN AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 66. LATIN AMERICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 67. EUROPE, MIDDLE EAST & AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 68. EUROPE, MIDDLE EAST & AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 69. EUROPE, MIDDLE EAST & AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 70. EUROPE, MIDDLE EAST & AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 71. EUROPE, MIDDLE EAST & AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 72. EUROPE WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 73. EUROPE WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 74. EUROPE WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 75. EUROPE WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 76. EUROPE WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 77. MIDDLE EAST WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 78. MIDDLE EAST WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 79. MIDDLE EAST WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 80. MIDDLE EAST WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 81. MIDDLE EAST WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 82. AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 83. AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 84. AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 85. AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 86. AFRICA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 87. ASIA-PACIFIC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 88. ASIA-PACIFIC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 89. ASIA-PACIFIC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 90. ASIA-PACIFIC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 91. ASIA-PACIFIC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 92. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 93. ASEAN WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 94. ASEAN WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 95. ASEAN WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 96. ASEAN WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 97. ASEAN WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 98. GCC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 99. GCC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 100. GCC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 101. GCC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 102. GCC WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 103. EUROPEAN UNION WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 104. EUROPEAN UNION WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 105. EUROPEAN UNION WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 106. EUROPEAN UNION WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 107. EUROPEAN UNION WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 108. BRICS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 109. BRICS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 110. BRICS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 111. BRICS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 112. BRICS WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 113. G7 WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 114. G7 WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 115. G7 WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 116. G7 WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 117. G7 WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 118. NATO WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 119. NATO WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 120. NATO WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 121. NATO WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 122. NATO WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 123. GLOBAL WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 124. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 125. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 126. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 127. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 128. UNITED STATES WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 129. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 130. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
• TABLE 131. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 132. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 133. CHINA WHOLE BODY ULTRASOUND EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)